K. Ogura et al., THE SIGNIFICANCE OF A POSITIVE FLOW-CYTOMETRY CROSS-MATCH TEST IN PRIMARY KIDNEY-TRANSPLANTATION, Transplantation, 56(2), 1993, pp. 294-298
This study was conducted to determine the efficacy of the T cell flow
cytometry crossmatch (T-FCXM) test in 841 first cadaver donor transpla
nts. Results showed one-year graft survival rates were 82% for T-FCXM-
negative patients, compared with 75% for T-FCXM-positive patients (P =
0.01). Early one-month graft failure was 13 percentage points higher
in those with a positive T-FCXM than those with a negative T-FCXM. The
positive crossmatch patients also had more frequent immunological fai
lures. A positive T-FCXM was found in 39% of the sensitized patients (
PRA > 10%) and 8% of those who had not been sensitized. Patients with
a positive T-FCXM in either category had a 74% graft survival rate. Th
us, most of the T-FCXM-positive results occurred in patients with comp
lement-fixing antibodies. It is suggested that flow cytometry crossmat
ching (FCXM) be used prospectively, despite the fact that many patient
s with a positive crossmatch did have successful transplants (TXs). In
the current climate of a cadaver kidney scarcity and large recipient
waiting pools, utilization of kidneys for patients with the highest pr
obability of success seems a most prudent policy.